IL1B and ovarian carcinoma: The analysis showed significant changes in the concentrations of individual IL-1 family member systems between the reference group and the study group in serum, as well as between different degrees of histological differentiation in both serum and peritoneal fluid, indicating that modulation of IL-1 family cytokine systems may affect the inflammatory process that accompanies the development of ovarian cancer.